E-LIB Suche - Ergebnisse für: Kishtagari, A

1

Topic: AS08-Treatment/AS08f-Clinical trials – Phase II-III:..:

Watts, J. ; Smith, B. ; Bradley, T....
Leukemia Research. 128 (2023) - p. 107272 , 2023

Link: https://doi.org/10.1016/..

2

P587: COVALENT-101: A PHASE 1 STUDY OF BMF-219, A NOVEL ORA..:

Ravandi-Kashani, F. ; Kishtagari, A. ; Carraway, H....
HemaSphere. 6 (2022) - p. 486-487 , 2022

Link: https://doi.org/10.1097/..

3

P1005: A PHASE 1, OPEN-LABEL, DOSE-ESCALATION STUDY OF SELI..:

Ali, H. ; Kishtagari, A. ; Maher, K....
HemaSphere. 6 (2022) - p. 895-896 , 2022

Link: https://doi.org/10.1097/..

4

Cost-Effective and Scalable Clonal Hematopoiesis Assay Prov..:

Mack, Taralynn ; Vlasschaert, Caitlyn ; von Beck, Kelly...
The Journal of Molecular Diagnostics. 26 (2024) 7 - p. 563-573 , 2024

Link: https://doi.org/10.1016/..

5

Venetoclax and hypomethylating agents in octogenarians and ..:

Madarang, Ellen ; Lykon, Jillian ; Zhao, Wei...
Blood Neoplasia. 1 (2024) 2 - p. 100016 , 2024

Link: https://doi.org/10.1016/..

6

Clonal hematopoiesis and inflammation in the vasculature: C..:

Shannon, Morgan L. ; Heimlich, J. Brett ; Olson, Sydney...
Blood Advances. 8 (2024) 13 - p. 3453-3463 , 2024

Link: https://doi.org/10.1182/..

7

Distinct bone marrow findings associated with a noncanonica..:

Allison, Devin R. ; Dholaria, Bhagirathbhai ; Kishtagari, Ashwin...
American Journal of Hematology. 99 (2024) 7 - p. 1400-1402 , 2024

Link: https://doi.org/10.1002/..

8

Driver mutation zygosity is a critical factor in predicting..:

Kishtagari, Ashwin ; Khan, M. A. Wasay ; Li, Yajing...
Blood Cancer Journal. 14 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

9

AML-522 COVALENT-101: Phase I Study of BMF-219, a Covalent ..:

Ravandi, Farhad ; Lancet, Jeffrey ; Amor, Adrian Alegre...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S310-S311 , 2023

Link: https://doi.org/10.1016/..

10

MPN-336 Selinexor Plus Ruxolitinib in JAK Inhibitor (JAKi) ..:

Ali, Haris ; Kishtagari, Ashwin ; Maher, Keri...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S389 , 2023

Link: https://doi.org/10.1016/..

11

P1020: SELINEXOR (SEL) PLUS RUXOLITINIB (RUX) IN JAK INHIBI..:

Ali, Haris ; Kishtagari, Ashwin ; Maher, Keri...
HemaSphere. 7 (2023) S3 - p. e402391a , 2023

Link: https://doi.org/10.1097/..

12

TP53 Mutations Are Associated with Increased Infections and..:

Marvin-Peek, Jennifer ; Mason, Emily F. ; Kishtagari, Ashwin...
Transplantation and Cellular Therapy. 29 (2023) 6 - p. 390.e1-390.e10 , 2023

Link: https://doi.org/10.1016/..

13

POSTER: AML-522 COVALENT-101: Phase I Study of BMF-219, a C..:

Ravandi, Farhad ; Lancet, Jeffrey ; Amor, Adrian Alegre...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S171 , 2023

Link: https://doi.org/10.1016/..

14

Patient-specific comorbidities as prognostic variables for ..:

Sochacki, Andrew L. ; Bejan, Cosmin Adrian ; Zhao, Shilin...
Blood Advances. 7 (2023) 5 - p. 756-767 , 2023

Link: https://doi.org/10.1182/..

15

P-213 COVALENT-101: phase I study of BMF-219, a covalent me..:

Rosenberg, Aaron ; Baljevic, Muhamed ; Amor, Adrian Alegre...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S152-S153 , 2023

Link: https://doi.org/10.1016/..